Genes, Gendered Contexts, and Substance Use Outcomes

基因、性别背景和药物使用结果

基本信息

项目摘要

DESCRIPTION (provided by applicant): It is becoming increasingly clear that risk factors for use and trajectories toward desistance may differ significantly for men and women (e.g., Westermeyer & Boedicker, 2000). For example, recent work has uncovered different effects of monoamine genotypes (e.g., serotonin transporter, MAO-A) on male and female psychopathology and behavior (Sjoberg et al., 2007a; Verona, Joiner, Johnson & Bender, 2006). In addition, there is evidence that pubertal onset, childhood sexual abuse, and intimate partner violence (IPV) constitute unique risk factors for antisocial behavior and drug use among women compared to men (Dick, Rose, Kaprio, & Viken, 2000) and can predict drug relapse in women many years later in adulthood (Hyman, Garcia, & Sinha, 2006). Thus, a primary goal of the present application is to identify gender differences in biological and environmental risk factors for substance use outcomes as a way of advancing nuanced conceptualizations of female drug problems. The current project intends to (1) explore various gene by environment (GxE) effects on drug use outcomes, by examining different monoamine genes (5HTT, DRD4, MAO-A) and incorporating gendered environmental risk factors that are not commonly included in studies of drug use (e.g., intimate partner violence), (2) examine the extent to which GxE effects or individual risk factors are specific to substance use outcomes in women relative to men, and (3) identify multivariate models involving GxE effects and mediators of these effects to predict substance use pathways in men and women. The goal is to examine not only GxE effects (e.g., gene-by-abuse, gene-by-IPV) that directly influence substance use outcomes, but identify potential mediators (pubertal development, internalizing symptoms) in an effort to understand nuanced pathways for female substance use. The ultimate goal is to help in the development of tailored interventions to address gender-specific manifestations and etiologies. PUBLIC HEALTH RELEVANCE: Women's drug arrests have increased in the last two decades, whereas men's arrests have decreased. Thus, women's drug use has become a significant social problem. An innovative aspect of the project is the attempt to identify genetic and environmental factors that are female specific for substance use outcomes. Given important sex differences in biology, gene expression, and motives, this project can inform psychosocial and pharmacological treatments for substance use so that they are tailored to address gender-specific issues.
描述(由申请人提供):越来越明显的是,男性和女性的使用风险因素和戒烟轨迹可能存在显着差异(例如,Westtermeyer & Boedicker,2000)。例如,最近的工作揭示了单胺基因型(例如,血清素转运蛋白,MAO-A)对男性和女性精神病理学和行为的不同影响(Sjoberg et al., 2007a; Verona, Joiner, Johnson & Bender, 2006)。此外,有证据表明,与男性相比,青春期开始、儿童期性虐待和亲密伴侣暴力 (IPV) 构成女性反社会行为和吸毒的独特危险因素 (Dick, Rose, Kaprio, & Viken, 2000),并且可以预测女性成年后多年吸毒的复发 (Hyman, Garcia, & Sinha, 2006)。因此,本申请的主要目标是确定物质使用结果的生物和环境风险因素中的性别差异,作为推进女性毒品问题的细致概念化的一种方式。当前项目打算 (1) 通过检查不同的单胺基因(5HTT、DRD4、MAO-A)并纳入吸毒研究中不常见的性别环境风险因素(例如亲密伴侣暴力),探索各种基因环境 (GxE) 对吸毒结果的影响,(2) 检查 GxE 影响或个人风险因素对女性物质使用结果的特定程度(相对于女性) (3) 确定涉及 GxE 效应和这些效应中介因素的多变量模型,以预测男性和女性的物质使用途径。目标不仅是检查直接影响物质使用结果的 GxE 效应(例如基因滥用、基因 IPV),还要确定潜在的中介因素(青春期发育、内化症状),以努力了解女性物质使用的微妙途径。最终目标是帮助制定量身定制的干预措施,以解决特定性别的表现和病因。 公共卫生相关性:过去二十年,女性因毒品被捕的人数有所增加,而男性因毒品被捕的人数有所减少。因此,妇女吸毒已成为一个重大的社会问题。该项目的一个创新方面是尝试确定女性特有的物质使用结果的遗传和环境因素。鉴于生物学、基因表达和动机方面存在重要的性别差异,该项目可以为药物滥用的心理社会和药物治疗提供信息,以便针对特定性别的问题进行定制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EDELYN VERONA其他文献

EDELYN VERONA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EDELYN VERONA', 18)}}的其他基金

Genes, Gendered Contexts, and Substance Use Outcomes
基因、性别背景和药物使用结果
  • 批准号:
    8298516
  • 财政年份:
    2011
  • 资助金额:
    $ 18.41万
  • 项目类别:
Emotional and Cognitive risk factors for aggression
攻击行为的情绪和认知风险因素
  • 批准号:
    6679071
  • 财政年份:
    2003
  • 资助金额:
    $ 18.41万
  • 项目类别:
Emotional and Cognitive risk factors for aggression
攻击行为的情绪和认知风险因素
  • 批准号:
    6796799
  • 财政年份:
    2003
  • 资助金额:
    $ 18.41万
  • 项目类别:
THE ROLE OF NEGATIVE EMOTION IN AGGRESSIVE BEHAVIOR
负面情绪在攻击性行为中的作用
  • 批准号:
    6208619
  • 财政年份:
    2000
  • 资助金额:
    $ 18.41万
  • 项目类别:

相似海外基金

Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The impact of changes in social determinants of health on adolescent and young adult mental health during the COVID-19 pandemic: A longitudinal study of the Asenze cohort in South Africa
COVID-19 大流行期间健康社会决定因素的变化对青少年和年轻人心理健康的影响:南非 Asenze 队列的纵向研究
  • 批准号:
    10755168
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
A Priority Setting Partnership to Establish a Patient, Caregiver, and Clinician-identified Research Agenda for Adolescent and Young Adult Cancer in Canada
建立优先合作伙伴关系,以建立患者、护理人员和临床医生确定的加拿大青少年和年轻人癌症研究议程
  • 批准号:
    480840
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Miscellaneous Programs
Incidence and Time on Onset of Cardiovascular Risk Factors and Cardiovascular Disease in Adult Survivors of Adolescent and Young Adult Cancer and Association with Exercise
青少年和青年癌症成年幸存者心血管危险因素和心血管疾病的发病率和时间以及与运动的关系
  • 批准号:
    10678157
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
Fertility experiences among ethnically diverse adolescent and young adult cancer survivors: A population-based study
不同种族青少年和年轻成年癌症幸存者的生育经历:一项基于人群的研究
  • 批准号:
    10744412
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
Treatment development for refractory leukemia using childhood/adolescent, and young adult leukemia biobank
利用儿童/青少年和青年白血病生物库开发难治性白血病的治疗方法
  • 批准号:
    23K07305
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular design of Two-Way Player CAR-T cells to overcome disease/antigen heterogeneity of childhood, adolescent, and young adult cancers
双向 CAR-T 细胞的分子设计,以克服儿童、青少年和年轻成人癌症的疾病/抗原异质性
  • 批准号:
    23H02874
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Effects of adolescent social isolation on adult decision making and corticostriatal circuitry
青少年社会隔离对成人决策和皮质纹状体回路的影响
  • 批准号:
    10756652
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
Adolescent trauma produces enduring disruptions in sleep architecture that lead to increased risk for adult mental illness
青少年创伤会对睡眠结构产生持久的破坏,从而导致成人精神疾病的风险增加
  • 批准号:
    10730872
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
Using Tailored mHealth Strategies to Promote Weight Management among Adolescent and Young Adult Cancer Survivors
使用量身定制的移动健康策略促进青少年和年轻癌症幸存者的体重管理
  • 批准号:
    10650648
  • 财政年份:
    2023
  • 资助金额:
    $ 18.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了